secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2026-09-14T20:46:13+00:00
Accession:  0001140361-26-036499
Event type: litigation
Sentiment:  negative
Materiality: 0.55
Item codes: 8.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne discloses merger proxy lawsuit, supplements disclosures
------------------------------------------------------------------

- Shareholder lawsuit filed Sept 9, 2026 in Minnesota court alleges proxy omitted material info; seeks to block merger vote.
- Bio-Techne denies merit, voluntarily supplements proxy; says disclosures comply with law.
- Supplement reveals Goldman Sachs implied present value of $58-$72/share (DCF) and $45-$74/share (multiple-based).
- Also discloses no post-closing employment discussions with merger parties from July 2025 to agreement execution.
- Special meeting for Merck KGaA merger vote remains scheduled for Sept 23, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000114036126036499/0001140361-26-036499-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000114036126036499/ef20081960_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-036499

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer